Industrial pharmaceutical pipettes on machine

UK-Japan trade agreement to bolster pharmaceutical industry

As part of a wide-reaching future trade deal struck between the UK Government and Japan last week, pharmaceutical companies from both countries will be able to largely continue to operate as normal come January 1, 2021.

With the UK set to exit the European Union at the end of the year, a number of new trade agreements with international partners are being struck to ensure the UK is largely unaffected economically. This includes aspects of the deals which directly impact the health and pharmaceutical industries.

In 2019, the UK exported £23.3bn worth of pharmaceutical goods.

Japan received 3.3% of those goods, to a value of £760m, making pharmaceutical goods the third-highest good in terms of value exported between the UK and Japan.

Crucially, as part of the newly-agreed Free Trade Agreement between the two countries, the UK and Japan will incorporate the functions of the existing EU/Japan Mutual Recognition Agreement (MRA) for medicines, meaning both sides will continue to accept each other’s drug safety testing and inspections before export.

Having an MRA in place avoids unnecessary duplication, disruption to supply chains or delays to patient access to medicine.

In response to the agreed deal, Claire Machin, Head of International Policy at the ABPI, said: “The UK-Japan agreement provides much-needed continuity to businesses in our sector as they focus on preparations for the end of the Transition Period.

“These early deals are an opportunity for the Government to set out a future trade agenda which supports innovative British industries, encourages R&D investment and strengthens the UK’s role as a leader in life sciences. We look forward to working with them to achieve that in future agreements."

Read more about Brexit and it's impacts on healthcare through our dedicated Brexit Resource Hub:

Brexit series - Boris Johnson banner

 

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all